Compass Pathways Reports Positive Phase 3 Results For Psilocybin In ...

One Dose Of 'Magic Mushrooms' Provides 5 Years Of Depression Relief: Study

A single dose of psilocybin, found in magic mushrooms, combined with therapy, provided over two years of relief from depression and anxiety for cancer patients, according to a new study.

Compass Pathways Reports Positive Phase 3 Results For Psilocybin In ...

Compass's Psychedelic Drug Hits Goal in Depression

Cautious Optimism, Lingering Questions: Researchers React to Compass’ Phase 3 Psilocybin Results - Psychedelic Alpha

It’s been two days since Compass Pathways provided a first look at data from its Phase 3 program, by way of a limited readout from COMP005, a placebo-controlled study of its COMP360 psilocybin in treatment-resistant depression (TRD). (See Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle.) The stock market had a similarly dramatic reaction to that seen in 2021, when the company posted Phase… Source

Clinical Trial Finds Psilocybin Therapy More Effective Than Escitalopram in Reducing Negative Thinking in Depression

The Marijuana Herald - Marijuana news and information A new clinical trial finds that psilocybin therapy may offer a more powerful remedy for negative thought patterns in people with major depressive disorder than the commonly prescribed antidepressant escitalopram. Researchers from Imperial College London and the University of California analyzed data from a randomized, controlled study comparing two high-dose psilocybin therapy sessions to six…

Psilocybin Safe, Effective for Treatment-Resistant Depression: Phase 3 Data

A single dose of a synthetic form of psilocybin is safe and clinically meaningful in reducing treatment-resistant depression, topline results from a phase 3 trial suggest.